Avalo Therapeutics Inc (AVTX) — Cash Flow Quality Index
Avalo Therapeutics Inc (AVTX) has a Cash Flow Quality Index of -0.50x as of September 2024. Operating cash flow of $-11.53 Million is below net income of $23.04 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of Avalo Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Avalo Therapeutics Inc Cash Flow Quality Index (2017–2017)
Historical Cash Flow Quality Index for Avalo Therapeutics Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see AVTX operating cash flow.
Annual Cash Flow Quality Index for Avalo Therapeutics Inc (2017–2017)
Year-by-year earnings quality comparison for Avalo Therapeutics Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2017 | 1.05x | $12.52 Million | $11.87 Million | — |